Table 3. Participant knowledge regarding lung biomarker screening at baseline and after web-based tool: n=40 participants.

True/false questions	Choosing response marked as “true”, n (%)		P value
	Baseline	After web-based tool
Lung nodules are quite common and may be an incidental finding	25 (62.5)	35 (87.5)	N/S
Lung nodules are usually cancerous	28 (70.0)	15 (37.5)	N/S
Biomarker testing helps identify patients with likely benign nodule	20 (50.0)	32 (80.0)	N/S
Biomarker testing helps physician decide whether invasive intervention is needed	19 (47.5)	26 (65.0)	N/S
Biomarker testing supports clinical decision-making	22 (55.0)	33 (82.5)	N/S

N/S, none significant.